Covariate-adjusted response-adaptive designs for longitudinal treatment responses: PEMF trial revisited

Response-adaptive designs have become popular for allocation of the entering patients among two or more competing treatments in a phase III clinical trial. Although there are a lot of designs for binary treatment responses, the number of designs involving covariates is very small. Sometimes the patients give repeated responses. The only available response-adaptive allocation design for repeated binary responses is the urn design by Biswas and Dewanji [Biswas A and Dewanji AA. Randomized longitudinal play-the-winner design for repeated binary data. ANZJS 2004; 46: 675–684; Biswas A and Dewanji A. Inference for a RPW-type clinical trial with repeated monitoring for the treatment of rheumatoid arthritis. Biometr J 2004; 46: 769–779.], although it does not take care of the covariates of the patients in the allocation design. In this article, a covariate-adjusted response-adaptive randomisation procedure is developed using the log-odds ratio within the Bayesian framework for longitudinal binary responses. The small sample performance of the proposed allocation procedure is assessed through a simulation study. The proposed procedure is illustrated using some real data set.

[1]  A. Biswas,et al.  Marginal Regression for Binary Longitudinal Data in Adaptive Clinical Trials , 2005 .

[2]  S. D. Durham,et al.  A sequential design for maximizing the probability of a favourable response , 1998 .

[3]  M. Zelen,et al.  Play the Winner Rule and the Controlled Clinical Trial , 1969 .

[4]  Atanu Biswas,et al.  Bayesian Adaptive Biased‐Coin Designs for Clinical Trials with Normal Responses , 2005, Biometrics.

[5]  Uttam Bandyopadhyay,et al.  Adaptive designs for normal responses with prognostic factors , 2001 .

[6]  Anthony C. Atkinson,et al.  Optimum Experimental Designs , 1992 .

[7]  A RANDOMIZED LONGITUDINAL PLAY‐THE‐WINNER DESIGN FOR REPEATED BINARY DATA , 2004 .

[8]  William F Rosenberger,et al.  Response-adaptive randomization for clinical trials with continuous outcomes. , 2006, Biometrics.

[9]  Scott L. Zeger,et al.  The analysis of binary longitudinal data with time independent covariates , 1985 .

[10]  Li-Xin Zhang,et al.  Asymptotic properties of covariate-adjusted response-adaptive designs , 2006 .

[11]  Atanu Biswas,et al.  Optimal Three-Treatment Response-Adaptive Designs for Phase III Clinical Trials with Binary Responses , 2007 .

[12]  P. Laycock,et al.  Optimum Experimental Designs , 1995 .

[13]  V. Jowaheer,et al.  Analyzing longitudinal count data from adaptive clinical trials: a weighted generalized quasi-likelihood approach , 2006 .

[14]  Anastasia Ivanova,et al.  A play-the-winner-type urn design with reduced variability , 2003 .

[15]  Feifang Hu,et al.  Maximizing power and minimizing treatment failures in clinical trials , 2004, Clinical trials.

[16]  A. Biswas,et al.  Inference for a RPW‐Type Clinical Trial with Repeated Monitoring for the Treatment of Rheumatoid Arthritis , 2004 .

[17]  Atanu Biswas,et al.  Optimal Response‐Adaptive Designs for Continuous Responses in Phase III Trials , 2007, Biometrical journal. Biometrische Zeitschrift.

[18]  Lanju Zhang,et al.  Response-adaptive randomization for survival trials: the parametric approach , 2007 .

[19]  ALLOCATION BY RANDOMIZED PLAY-THE-WINNER RULE IN THE PRESENCE OF PROGNOSTIC FACTORS , 2002 .

[20]  L. J. Wei,et al.  The Randomized Play-the-Winner Rule in Medical Trials , 1978 .

[21]  Atanu Biswas,et al.  Optimal Adaptive Designs in Phase III Clinical Trials for Continuous Responses with Covariates , 2004 .

[22]  William F. Rosenberger,et al.  Optimality, Variability, Power , 2003 .

[23]  Uttam Bandyopadhyay,et al.  A covariate adjusted two‐stage allocation design for binary responses in randomized clinical trials , 2007, Statistics in medicine.

[24]  W. Rosenberger,et al.  Randomization in Clinical Trials: Theory and Practice , 2002 .

[25]  W. Rosenberger,et al.  COVARIATE-ADJUSTED RESPONSE-ADAPTIVE DESIGNS FOR BINARY RESPONSE , 2001, Journal of biopharmaceutical statistics.